Fig. 3
Antibiotics used in definitive therapy in invasive pneumococcal diseases (meningitis and non-meningitis cases) whose isolates were susceptible to cefotaxime
Fig. 3 | BMC Infectious Diseases
Antibiotics used in definitive therapy in invasive pneumococcal diseases (meningitis and non-meningitis cases) whose isolates were susceptible to cefotaxime